Osteoarthritis Trial, Recruiting NCT06914960 Sponsor: Bengu Turemenogullari Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06914960
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 30 and 75 years old
  • People who have had ongoing knee pain for at least 6 months
  • People whose X-rays show moderate to severe osteoarthritis (Grade 3 or 4 on a standard medical scale) with significant narrowing of the space inside the knee joint
  • People whose knee pain scores above 40 out of 100 on a pain scale when doing one of the two most painful movements, such as sitting down and standing up, or going up and down stairs
  • People whose pain reduced by at least 50% after a specific diagnostic nerve-blocking injection to the knee (confirm with trial site)

Who may not be able to join:

  • People who have a whole-body inflammatory disease such as rheumatoid arthritis
  • People who have had a radiofrequency nerve treatment to the knee, or a hyaluronic acid or steroid injection into the knee, within the past 3 months
  • People who have had any previous knee surgery
  • People who have significant knee problems other than osteoarthritis that may be causing their chronic knee pain
  • People who have had physical therapy for their knee in the last 6 months, or who have a history of knee injury
  • People who are currently receiving other pain treatments
  • People whose Body Mass Index (a measure of body weight relative to height) is below 18 or above 40
  • People who are pregnant
  • People who have a serious uncontrolled illness (such as cancer or diabetes), an active infection, a psychiatric disorder, or a condition that affects blood clotting

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905072848966

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Bengu Turemenogullari
Registry
ClinicalTrials.gov
Start date
15 April 2025
Est. completion
31 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Cybex 770, Humac Norm Dynamometer (CSMI, Stoughton, MA, USA): Isokinetic muscle strength of the quadriceps and hamstring muscles; HUBER 360 Evolution Device (LPG, Valence, France); Cybex 770, Humac Norm dynamometer (CSMI, Stoughton, MA, USA): Proprioception of the knee joint

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov